[1,4]benzoquinone; compound with pyrocatechol | 101732-60-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: [1,4]benzoquinone; compound with pyrocatechol
• 英文别名: [1,4]Benzochinon; Verbindung mit Brenzcatechin；[1,4]Benzochinon; Verbindung mit Brenzcatechin (1:1)；Benzene-1,2-diol;cyclohexa-2,5-diene-1,4-dione
• CAS: 101732-60-9
• 化学式: C₆H₄O₂*C₆H₆O₂
• 分子量: 218.209
• InChiKey: HQSINFVOKDNIQJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.35
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  邻苯二酚 、 对苯醌 在 乙醚 作用下， 生成 [1,4]benzoquinone; compound with pyrocatechol
  参考文献：
  名称：

  Meyer,K. H., Chemische Berichte, 1909, vol. 42, p. 1153

  摘要：

  DOI：

文献信息

• Plasma deposition method for catechol/quinone functionalised layers
  申请人：Luxembourg Institute of Science and Technology (LIST)

  公开号：US10843224B2

  公开（公告）日：2020-11-24

  A solvent-free plasma method for depositing an adherent catechol and/or quinone functionalised layer to an inorganic or organic substrate from a precursor which comprises at least a quinone group; a protected or unprotected catechol group; a molecule substituted by a quinone group and/or a protected or unprotected catechol group; and/or a natural or synthetic derivative of a catechol group and/or a quinone group; wherein the quinone group is a 1,2-benzoquinone group and the catechol group is a 1,-dihydroxybenzene group.

  一种无溶剂等离子体方法，用于在无机或有机基底上沉积附着的邻苯二酚和/或醌功能化层，其前体至少包括一个醌基团；一个受保护或不受保护的邻苯二酚基团；被醌基和/或受保护或未受保护的邻苯二酚基取代的分子；和/或邻苯二酚基和/或醌基的天然或合成衍生物；其中醌基为 1,2-苯醌基，邻苯二酚基为 1,-二羟基苯基。
• Unifying mechanism and methods to prevent cancer and neurodegenerative diseases
  申请人：Cavalieri L. Ercole

  公开号：US20050164911A1

  公开（公告）日：2005-07-28

  The present invention relates to methods for preventing the development of cancer or neurodegenerative diseases by administering N-Acetylcysteine (NAC), melatonin, or a combination thereof. The present invention also relates to methods for diagnosing cancer and/or neurdegenerative disease by detecting or determining the amount of dopamine metabolites, 4-CE, 2-CE, methylation of CE or CE-Q conjugates.

  本发明涉及通过施用N-乙酰半胱氨酸（NAC）、褪黑素或其组合预防癌症或神经退行性疾病发展的方法。本发明还涉及通过检测或确定多巴胺代谢物、4-CE、2-CE、CE甲基化或CE-Q共轭物的量来诊断癌症和/或神经退行性疾病的方法。
• Siegmund, Monatshefte fur Chemie, 1908, vol. 29, p. 1097
  作者：Siegmund

  DOI：——

  日期：——
• UNIFYING MECHANISM AND METHODS TO PREVENT CANCER AND NEURODEGENERATIVE DISEASES
  申请人：Cavalieri Ercole L.

  公开号：US20090312391A1

  公开（公告）日：2009-12-17

  The present invention relates to methods for preventing the development of cancer or neurodegenerative diseases by administering N-Acetylcysteine (NAC), melatonin, or a combination thereof. The present invention also relates to methods for diagnosing cancer and/or neurdegenerative disease by detecting or determining the amount of dopamine metabolites, 4-CE, 2-CE, methylation of CE or CE-Q conjugates.
• Plasma Deposition Method For Catechol/Quinone Functionalised Layers
  申请人：Luxembourg Institute of Science and Technology (LIST)

  公开号：US20170297055A1

  公开（公告）日：2017-10-19

  The invention provides a solvent-free plasma method for depositing an adherent catechol and/or quinone functionalised layer to an inorganic or organic substrate from a precursor which comprises at least a quinone group; a protected or unprotected catechol group; a molecule substituted by a quinone group and/or a protected or unprotected catechol group; and/or a natural or synthetic derivative of a catechol group and/or a quinone group; wherein the quinone group is a 1,2-benzoquinone group and the catechol group is a 1,2-dihydroxybenzene group.